Medical coders and billers must stay updated with coding changes to ensure accurate claims submission and proper reimbursement. The April 2026 quarterly update to the HCPCS Level II code set introduces several important changes that affect coding, billing, and payment policies.

These updates are part of revisions to the Medicare Physician Fee Schedule database and will be implemented starting April 1, 2026. Coders working with Medicare claims should review these updates carefully to avoid claim denials, payment delays, or compliance issues.

Let’s break down the changes in a simple and practical way for medical coders.

Key Highlights of the April 2026 HCPCS Level II Update

The April quarterly update includes the following changes:

• 36 new HCPCS Level II codes

• Procedure status indicator updates

• Short descriptor revisions

• Payment policy changes

• Retroactive updates effective January 1, 2026

These updates impact drug codes, supply codes, biologics, and skin substitute products, which are frequently billed in outpatient facilities and physician offices.

36 New HCPCS Level II Codes Added

The April update introduces 36 new HCPCS Level II codes, mainly for injectable drugs, biologics, and skin substitute products.

Below are some of the key additions.

New Drug and Injection Codes

Most of these J-codes represent new injectable drugs or biologics, which are commonly billed in oncology, infusion centers, and hospital outpatient departments.

New Skin Substitute Supply Codes

Several new Q-codes were added for skin substitute and biologic wound care products.

Examples include:

• Q4418 – Biolab Wrap Flow (per sq cm)

• Q4421 – Biolab Wrap Solo (per sq cm)

• Q4426 – Dermabond TL+ (per sq cm)

• Q4435 – Renati membrane (per sq cm)

• Q4439 – Instagraft (per sq cm)

• Q4440 – Curamatrix (per sq cm)

These products are commonly used in wound care procedures, skin grafting, and ulcer treatments.

Understanding Status Indicators

Each HCPCS code is assigned a status indicator, which determines how Medicare processes the code.

Here’s what the indicators mean:

MUST BUY CPT & ICD-10 CM  CODING EBOOKS 

Codes marked Carrier/MAC priced (C) mean reimbursement will be determined by your Medicare Administrative Contractors rather than a national payment rate.

Important Procedure Status Change

There is a significant update affecting one vascular procedure code.

CPT Code 37215

Code CPT 37215
(Transcatheter stent placement in the common carotid artery with embolic protection)

Change:
The co-surgery indicator is now “1.”

What this means for coders

• Two surgeons may be paid for the procedure

• Supporting documentation must justify medical necessity

• Both surgeons must use modifier 62 when appropriate

This change is especially relevant for interventional radiology and vascular surgery coding.

Short Descriptor Revision

One HCPCS code has a revised descriptor.

Code J0174

Old Descriptor

Injection, lecanemab-irmb, 1 mg

New Descriptor

Lecanemab-irmb, for IV injection

Although this change is minor, coders should ensure their chargemaster and billing systems reflect the updated wording.

Retroactive Changes Effective January 1, 2026

Some updates in this quarterly release apply retroactively to the start of 2026.

Key Retroactive Updates

• J1572 Flebogamma injection has been reinstated

• Assistant surgery indicator for CPT 1002T updated to 9

• Bilateral indicator for CPT 0971T updated to 1

Additionally, technical corrections were made to malpractice relative value units for several CPT codes including:

• 21610

• 22319

• 22554

• 33269

• 33983

• 37660

• 44322

• 58290

• 61320

Coders should verify that billing systems and payer policies reflect these corrected RVU values.

Important Reminder for Medical Coders

Although participating providers will receive update notifications from their Centers for Medicare & Medicaid Services, claims with outdated codes will not be automatically corrected.

This means coders must:

✔ Review new HCPCS codes
✔ Update billing software and chargemasters
✔ Verify payer policy changes
✔ Ensure documentation supports updated coding rules

Implementation Timeline

• Effective Date: April 1, 2026

• MAC Implementation Deadline: April 6, 2026

Full details can be found in CMS Transmittal 13648, which provides implementation instructions to MACs.

Additional CMS Updates Released

In addition to the HCPCS update, CMS also released April 2026 updates to:

• Clinical Laboratory Fee Schedule (CLFS)

• Vaccine Administration National Fee Schedule (VANFS)

One notable addition is HCPCS code Q0238, which describes TYENNE® (tocilizumab-aazg) used in COVID-19 treatment.

Final Thoughts for Medical Coders

Quarterly HCPCS updates are critical for maintaining coding accuracy and compliance. Missing these updates can lead to denied claims, incorrect reimbursement, and audit risks.

Medical coders working in:

• Outpatient facilities

• Infusion centers

• Interventional radiology

• Wound care clinics

should carefully review the new drug codes, skin substitute codes, and payment indicator changes included in this update.

Staying proactive with these updates ensures clean claims, faster reimbursement, and better coding compliance.

✅ Pro Tip for Coders:
Always review quarterly CMS updates and update your coding references, chargemaster, and billing software before submitting claims after the effective date.